- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
AHA/ACC & ESC/EAS Lipid Guidelines: Compare & Contrast Quiz
Dyslipidemia guidelines from the US and Europe take slightly different routes to similar ends. Test your knowledge of the twists and turns.
The 2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol (AHA/ACC) and the 2019 European Society of Cardiology/European Atherosclerosis Society Guidelines for the Management of Dyslipidaemias: Lipid Modificatnion to Reduce Cardiovascular Risk (ESC/EAS) share the common goal of reducing morbidity and mortality caused by cardiovascular disease. They differ, however, in definitions of risk, particularly in what constitutes a "high-risk" patient, and also in their goals for treatment.Follwing are 4 situations, including 3 hypothetical patients, that ask you to apply your knowledge of the differences between the European and US recommendations, followed by detailed rationale for the answers.
